The Technical Analyst
Select Language :
Medtronic PLC [2M6.DE]

Exchange: XETRA Industry: Health Care Equipment & Services

Medtronic PLC Price, Forecast, Insider, Ratings, Fundamentals & Signals

Medtronic PLC is listed at the  Exchange

-0.32% €75.25

Europe/Berlin / 2 mai 2024 @ 17:35


FUNDAMENTALS
MarketCap: 99 918 mill
EPS: 2.94
P/E: 25.60
Earnings Date: May 23, 2024
SharesOutstanding: 1 327.82 mill
Avg Daily Volume: 0.0010 mill
RATING 2024-05-02
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Buy
Return On Asset: Buy
DE: Buy
P/E: Buy
Price To Book: Neutral
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
1.41x
Company: PE 25.60 | sector: PE 18.22
PE RATIO: COMPANY / INDUSTRY
0.86x
Company: PE 25.60 | industry: PE 29.80
DISCOUNTED CASH FLOW VALUE
€51.97
(-30.94%) €-23.28
Date: 2024-05-02
Expected Trading Range (DAY)

€ 74.20 - 76.64

( +/- 1.61%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €75.74
Forecast 2: 16:00 - €75.74
Forecast 3: 16:00 - €75.74
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price €75.25 (-0.32% )
Volume 0.0008 mill
Avg. Vol. 0.0010 mill
% of Avg. Vol 80.33 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Medtronic PLC

Last 12 Months

Last 12 months chart data with high, low, open and close for Medtronic PLC

RSI

Last 10 Buy & Sell Signals For 2M6.DE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Medtronic PLC

2M6.DE

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Last 10 Buy Signals

Date Signal @
TETUSDMay 2 - 20:3516.65
CVCUSDMay 2 - 20:36$0.155
KAVAUSDMay 2 - 20:33$0.658
HBARUSDMay 2 - 20:33$0.0990
USDDUSDMay 2 - 20:310.991
GALUSDMay 2 - 20:302.25
DPIUSDMay 2 - 20:31$92.39
ANKRETHUSDMay 2 - 20:313 435.15
OKTUSDMay 2 - 20:3013.44
POWRUSDMay 2 - 20:27$0.286

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.